Themis Medicare Ltd.

BSE: THEMISMED530199ISIN INE083B01024

Healthcare
Pharmaceuticals
BSE Healthcare

Share price

₹100.36+1.12 (+1.13%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹141.05
52W low: ₹65.00
Off 52W high: -28.85%
1M return: -10.55%
3M return: -13.18%
6M return: +0.86%
1Y return: -17.87%
20D avg volume: 3,807
50 DMA: ₹114.10
200 DMA: ₹100.77

Key ratios Consolidated

Market cap: ₹924.32 Cr
Current price: ₹100.36
52W high / low: ₹141.05 / ₹65.00
Face value: ₹1.00
P/E: 23.12
P/B: 2.32
EPS (TTM): ₹4.34
Book value / share: ₹43.28
ROE: —
ROCE: -0.30%
Operating margin: —
Net margin: —
Debt / equity: 0.25
Net debt: ₹95.55 Cr
Interest cover: -0.13
Dividend yield: 0.50%
Dividend / share (TTM): ₹0.50
Payout: 11.52%
Cash conversion cycle: 222.3 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	86.96	76.53	90.13	77.99	97.58	71.70	93.81	117.01	122.99	97.82	82.51	104.78
	0.99	3.67	1.28	3.24	1.18	1.55	1.02	1.14	0.96	1.10	0.56	2.44
	87.95	80.20	91.42	81.23	98.75	73.25	94.83	118.15	123.95	98.92	83.08	107.22
	144.90	78.07	85.68	86.42	112.68	82.47	90.61	104.78	98.58	93.74	80.23	97.48
	17.63	14.27	14.50	16.11	12.43	18.98	12.76	21.06	23.52	21.65	21.14	26.18
	49.81	11.46	11.63	18.23	21.68	16.30	22.51	18.12	16.74	11.79	18.11	13.92
	22.18	21.06	22.68	24.93	24.85	25.45	24.95	24.38	21.59	22.46	19.92	19.86
	2.98	2.70	2.75	2.77	2.47	2.45	2.79	2.44	2.36	2.16	2.69	2.04
	2.54	2.60	2.59	2.58	2.55	2.53	2.54	2.45	2.41	3.06	3.10	3.07
	59.21	27.96	28.48	32.01	30.41	31.45	31.82	33.87	30.95	26.84	28.05	30.58
	-56.95	2.13	5.74	-5.19	-13.93	-9.21	4.22	13.37	25.37	5.18	2.85	9.74
	92.95	0.00	-0.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	36.01	2.13	4.87	-5.19	-13.93	-9.21	4.22	13.37	25.37	5.18	2.85	9.74
	13.99	0.17	0.29	0.17	0.16	1.46	1.14	3.50	6.66	2.11	0.85	2.64
	24.61	8.89	10.09	-3.62	-14.22	-9.66	0.52	14.29	24.68	6.64	7.37	11.32
	2.67	0.96	1.10	-0.39	-1.54	-1.05	0.06	1.55	2.68	0.72	0.80	12.30
Key metrics
	41.53	7.43	10.21	0.16	-8.91	-4.23	9.55	18.26	30.14	10.40	8.64	14.85
	47.80%	9.70%	11.30%	0.20%	-9.10%	-5.90%	10.20%	15.60%	24.50%	10.60%	10.50%	14.20%
	28.30%	11.60%	11.20%	-4.60%	-14.60%	-13.50%	0.60%	12.20%	20.10%	6.80%	8.90%	10.80%
	—	1.10%	—	-0.60%	—	-1.60%	—	—	—	—	—	—
	-10.90%	6.70%	-3.90%	-33.30%	-20.70%	-26.70%	13.70%	11.70%	—	—	—	—
	273.10%	192.00%	1,840.40%	-125.30%	-157.60%	-245.50%	-92.90%	26.20%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	331.61	342.24	405.51	381.76	354.32	394.61
	9.18	9.36	4.67	4.76	11.51	6.54
	340.80	351.60	410.18	386.52	365.83	401.15
	395.07	362.85	376.43	351.88	306.93	317.23
	62.51	57.30	76.31	84.67	96.04	113.63
	91.13	63.00	73.67	53.61	30.12	31.45
	90.85	93.52	96.38	82.41	66.14	51.97
	11.20	10.69	10.04	9.38	9.56	8.78
	10.31	10.32	9.93	12.25	10.49	9.48
	147.66	118.85	128.10	111.13	102.36	98.87
	-54.27	-11.26	33.75	34.64	58.90	83.92
	92.08	-0.87	0.00	0.00	0.00	0.00
	37.82	-12.12	33.75	34.64	58.90	83.92
	14.62	0.79	9.84	9.92	15.61	22.38
	39.97	1.14	29.83	43.52	56.90	72.88
	4.34	0.12	3.24	4.73	61.83	79.22
Key metrics
	59.33	8.89	53.72	56.27	78.95	102.18
	17.89%	2.60%	13.20%	14.70%	22.30%	25.90%
	12.05%	0.30%	7.40%	11.40%	16.10%	18.50%
	—	-0.30%	10.10%	—	—	—
	-12.76%	-15.60%	6.20%	7.70%	-10.20%	—
	—	-96.20%	-31.50%	-23.50%	-21.90%	—
	—	-8.14	19.28	—	—	—
	—	-2.87	1.16	—	—	—
	—	0.25	0.21	—	—	—
	—	95.55	76.43	—	—	—
	—	222.3	189.0	—	—	—
Balance sheet
	—	597.91	588.03	—	—	—
	—	304.98	303.87	—	—	—
	—	4.54	6.56	—	—	—
	—	178.12	177.10	—	—	—
	—	81.09	84.31	—	—	—
	—	30.21	23.40	—	—	—
	—	166.40	172.03	—	—	—
	—	50.84	51.44	—	—	—
	—	166.16	156.12	—	—	—
	—	100.09	82.99	—	—	—
	—	78.23	64.38	—	—	—
	—	21.86	18.61	—	—	—
	—	398.58	402.60	—	—	—
Cash flow
	—	-3.27	34.71	—	—	—
	—	-2.54	-12.17	—	—	—
	—	3.79	-25.90	—	—	—
	—	4.87	15.43	—	—	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	86.96	76.53	90.13	77.99	97.58	71.70	93.81	99.59	106.08	97.82	82.51	104.78
	0.99	3.67	1.28	3.24	1.18	1.55	1.02	0.77	0.71	1.10	0.56	2.44
	87.95	80.20	91.42	81.23	98.75	73.25	94.83	100.36	106.79	98.92	83.08	107.22
	144.90	78.06	85.68	86.42	112.68	82.46	90.61	85.23	79.28	93.72	80.23	97.48
	17.63	14.27	14.50	16.11	12.43	18.98	12.76	11.37	13.30	21.65	21.13	26.18
	49.81	11.46	11.63	18.23	21.68	16.30	22.51	18.12	16.74	11.79	18.11	13.92
	22.18	21.06	22.68	24.93	24.85	25.45	24.95	21.59	18.87	22.46	19.92	19.86
	2.98	2.70	2.75	2.76	2.47	2.45	2.79	1.60	1.44	2.16	2.68	2.04
	2.54	2.60	2.59	2.57	2.55	2.53	2.54	1.06	1.01	3.06	3.10	3.07
	59.21	27.95	28.48	32.01	30.41	31.44	31.83	28.57	26.55	26.82	28.04	30.58
	-56.95	2.14	5.74	-5.19	-13.93	-9.21	4.22	15.13	27.50	5.20	2.85	9.74
	99.67	0.00	-0.87	0.00	-1.29	0.00	—	—	—	—	—	—
	42.72	2.14	4.87	-5.19	-15.22	-9.21	4.22	15.13	27.50	5.20	2.85	9.74
	13.99	0.17	0.29	0.17	0.16	-1.46	1.14	3.94	7.20	2.11	0.85	2.64
	28.74	1.97	4.58	-5.36	-15.37	-7.75	3.08	9.87	18.71	3.09	2.00	7.10
	3.12	0.21	0.50	-0.58	-1.67	-0.84	0.33	1.22	2.20	0.34	0.22	7.71
Key metrics
	48.24	7.44	10.21	0.14	-10.20	-4.23	9.55	17.79	29.95	10.42	8.63	14.85
	55.50%	9.70%	11.30%	0.20%	-10.50%	-5.90%	10.20%	17.90%	28.20%	10.70%	10.50%	14.20%
	33.00%	2.60%	5.10%	-6.90%	-15.80%	-10.80%	3.30%	9.90%	17.60%	3.20%	2.40%	6.80%
	—	1.40%	—	-0.80%	—	-1.90%	—	—	—	—	—	—
	-10.90%	6.70%	-3.90%	-21.70%	-8.00%	-26.70%	13.70%	-5.00%	—	—	—	—
	287.00%	125.40%	48.70%	-154.30%	-182.10%	-350.80%	54.00%	39.00%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	331.61	342.24	405.51	381.76	354.32	394.61
	9.18	9.36	4.67	4.76	11.51	6.54
	340.80	351.60	410.18	386.52	365.83	401.15
	395.06	362.84	376.42	351.85	306.92	317.22
	62.51	57.30	76.31	84.67	96.04	113.63
	91.13	63.00	73.67	53.61	30.12	31.45
	90.85	93.52	96.38	82.41	66.15	51.97
	11.19	10.69	10.04	9.38	9.56	8.77
	10.30	10.32	9.93	12.25	10.49	9.48
	147.65	118.84	128.08	111.10	102.35	98.85
	-54.26	-11.24	33.76	34.67	58.91	83.94
	98.80	-2.16	0.00	—	—	—
	44.54	-13.40	33.76	34.67	58.91	83.94
	14.62	0.79	9.84	9.92	15.61	22.38
	29.93	-14.19	23.92	24.75	43.30	61.56
	3.25	-1.54	2.60	2.69	47.05	66.91
Key metrics
	66.03	7.61	53.73	56.30	78.96	102.19
	19.91%	2.20%	13.20%	14.70%	22.30%	25.90%
	9.03%	-4.10%	5.90%	6.50%	12.20%	15.60%
	—	-0.80%	12.50%	—	—	—
	-8.57%	-15.60%	6.20%	7.70%	-10.20%	—
	—	-159.30%	-3.40%	-42.80%	-29.70%	—
	—	-8.14	19.28	—	—	—
	—	0.23	1.45	—	—	—
	—	0.33	0.26	—	—	—
	—	95.64	76.52	—	—	—
	—	222.3	189.3	—	—	—
Balance sheet
	—	500.21	505.65	—	—	—
	—	304.99	305.15	—	—	—
	—	4.45	6.47	—	—	—
	—	178.12	177.46	—	—	—
	—	81.09	84.31	—	—	—
	—	30.32	24.43	—	—	—
	—	166.40	172.03	—	—	—
	—	50.84	51.44	—	—	—
	—	166.10	156.06	—	—	—
	—	100.09	82.99	—	—	—
	—	78.23	64.38	—	—	—
	—	21.86	18.61	—	—	—
	—	300.95	320.29	—	—	—
Cash flow
	—	-3.27	34.71	—	—	—
	—	-2.54	-12.17	—	—	—
	—	3.79	-25.90	—	—	—
	—	4.87	15.43	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: -1.15%
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -8.57%
Profit YoY (TTM): +394.30%

Consolidated

Sales CAGR 3Y: -1.15%
Sales CAGR 5Y: —
Profit CAGR 3Y: -72.84%
Profit CAGR 5Y: —
Sales YoY (TTM): -12.76%
Profit YoY (TTM): +540.68%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 67.11%

Quarter	September 2026	30 Jun 2026	June 2026	March 2026
Promoter %	67.11%	67.11%	67.11%	67.11%

Holder	Type	Holding	Previous	Change
DINESH SHANTILAL PATEL, JAYSHREE DINESH PATEL, SACHIN DINESH PATEL (TRUSTEES OF VIVIDHMARGI TRUST)	Promoter	27.49%	27.49%	0.00%
VIVIDHMARGI INVESTMENTS PVT	Promoter Group	26.52%	—	—
GEDEON RICHTER INVESTMENT MANAGEMENT LTD.	Promoter Group	9.60%	9.60%	0.00%
ANUJ ANANTRAI SHETH	Public	3.80%	—	—
ZAFAR AHMADULLAH	Public	2.11%	—	—
ZA CAPITAL SERVICES INDIA PRIVATE LTD	Public	1.53%	—	—
ANAY RUPEN CHOKSI	Promoter	1.28%	1.28%	0.00%
NYSHA RUPEN CHOKSI	Promoter	1.28%	1.28%	0.00%
L7 HITECH PRIVATE LIMITED	Public	1.08%	—	—
SHANTILAL DAHYABHAI PATEL HUF	Promoter	0.61%	0.61%	0.00%
DINESH SHANTILAL PATEL	Promoter	0.33%	0.33%	0.00%
SACHIN DINESH PATEL	Promoter	0.00%	0.00%	0.00%
RUPEN ASHWIN CHOKSI	Promoter	0.00%	0.00%	0.00%
JAYSHREE D PATEL	Promoter	0.00%	0.00%	0.00%
REENA S PATEL	Promoter	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Themis Medicare Ltd.	924	100.36	23.12	-0.30%	-12.76% TTM	+540.68% TTM	-17.87%

Filings & corporate actions

Recent announcements

The Board Meeting to be held on 05/11/2026 has been revised to 14/11/2026 The Board Meeting to be held on 05/11/2026 has been revised to 14/11/20262 Nov 2026 · Company Update / Board Meeting Rescheduled
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd30 Oct 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on October ....28 Oct 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 28, 2026 for Vividhmargi Investments Pvt Ltd28 Oct 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Themis Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve un-audited standalone and consolidated ....27 Oct 2026 · Board Meeting / Board Meeting
Kindly refer to our attached copies of Newspaper Articles of Postal Ballot Notice dated 24.10.202624 Oct 2026 · Company Update / Newspaper Publication
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on October ....24 Oct 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 23, 2026 for Vividhmargi Investments Pvt Ltd24 Oct 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Please refer to the intimation under Regulation 30 of SEBI (LODR) Regulations, 2015.23 Oct 2026 · Company Update / General
Kindly refer to the Notice of Postal Ballot dated 23.10.202623 Oct 2026 · AGM/EGM / Postal Ballot
Kindly refer to RTA compliance certificate for the quarter ended 30.09.202612 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Kindly refer to our intimation of credit rating.9 Oct 2026 · Company Update / Credit Rating
Please refer to our Scrutinizer''s Report of 56th Annual General Meeting of the Company.1 Oct 2026 · AGM/EGM / AGM
Kindly refer to the attachment.30 Sep 2026 · AGM/EGM / AGM
Intimation of revision in credit rating30 Sep 2026 · Company Update / Credit Rating
Please refer to the Intimation under Regulation 30 of SEBI (LODR) Regulations, 201530 Sep 2026 · Company Update / Amendments to Memorandum & Articles of Association
Please refer to the attachment.30 Sep 2026 · Company Update / Amendments to Memorandum & Articles of Association
Kindly refer to the Outcome of 56th Annual General Meeting of the Company.30 Sep 2026 · AGM/EGM / AGM
Please refer to our intimation under Regulation 30 for withdrawal of proposed preferential issue of 45,95,795 convertible equity warrants.24 Sep 2026 · Company Update / General
Please refer to our Intimation of closure of Trading window for the declaration of un-audited financial results for the quarter and half year ending 30.09.202623 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Please refer to the attachment.18 Sep 2026 · Corp. Action / Record Date
Please refer to Newspaper publication for Notice of 56th AGM scheduled on 30th September, 2026.9 Sep 2026 · Company Update / Newspaper Publication
Please refer to our BRSR for F.Y. 2025-268 Sep 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Please refer to our Annual Report for F.Y. 2025-268 Sep 2026 · Others / Reg. 34 (1) Annual Report
Please refer to the Notice of 56th AGM and Annual Report for F.Y. 2025-268 Sep 2026 · AGM/EGM / AGM
Please refer to our Intimation of change/updation in Email ID of Company Secretary and RTA.17 Aug 2026 · Company Update / General
Newspaper Publication of Un-audited Financial Results for the quarter ended 30th June, 202614 Aug 2026 · Company Update / Newspaper Publication
Investors Presentation for the quarter ended 30.06.202613 Aug 2026 · Company Update / Investor Presentation
Investors Presentation for the quarter ended 30.06.202613 Aug 2026 · Company Update / Investor Presentation
Please refer to the attachment.13 Aug 2026 · Company Update / General
Please refer to the attachment.13 Aug 2026 · Company Update / Resignation of Company Secretary / Compliance Officer
Please refer to the intimation of appointment of Company Secretary & Compliance Officer and Key Managerial Personnel of the Company.13 Aug 2026 · Company Update / Appointment of Company Secretary / Compliance Officer
Kindly refer to the attachment.13 Aug 2026 · Result / Financial Results
Please refer to the outcome of the Board Meeting held on 13th August 2026.13 Aug 2026 · Board Meeting / Outcome of Board Meeting
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd5 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Themis Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the Standalone and Consolidated ....31 Jul 2026 · Board Meeting / Board Meeting
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 30, 2026 for Vividhmargi Investments Pvt Ltd31 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 ....21 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 21, 2026 for Vividhmargi Trust21 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 20, 2026 for Vividhmargi ....21 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 0.5000	23 Sep 2026	23 Sep 2026	—
Final Dividend - Rs. - 0.5000	4 Sep 2025	5 Sep 2025	—
Final Dividend - Rs. - 0.5000	12 Jul 2024	—	—

Board meetings

14 Nov 2026 Board Meeting - Financial Results
5 Nov 2026 Board Meeting - Financial Results
13 Aug 2026 Board Meeting - Financial Results